Search research articles
Contact Us
Filters
Showing results (51-60 of 223) with videos related to
Page
of 23
Sort By:
The Journal of Infectious Diseases
|
November 7, 2012
Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment
Juliane Doerrbecker, Patrick Behrendt, Pedro Mateu-Gelabert, et al.
The Journal of Infectious Diseases
|
May 6, 2010
How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides
Sandra Ciesek, Martina Friesland, Jörg Steinmann, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 2, 2020
Lack of antiviral activity of darunavir against SARS-CoV-2
Sandra De Meyer, Denisa Bojkova, Jindrich Cinatl, et al.
Molecular & Cellular Proteomics : MCP
|
March 31, 2023
SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells
Melinda Metzler, Rebecca George Tharyan, Kevin Klann, et al.
Stem Cell Reports
|
September 20, 2020
Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells
Richard Schäfer, Gabriele Spohn, Marco Bechtel, et al.
Transplantation
|
March 15, 2006
Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients
Paraskevi Fytili, Sandra Ciesek, Michael P Manns, et al.
Frontiers in Immunology
|
June 8, 2023
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A Madhi, Benjamin J Cowling, et al.
PNAS Nexus
|
January 30, 2023
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
Lyudmila Shalamova, Ulrike Felgenhauer, Jochen Wilhelm, et al.
Frontiers in Immunology
|
June 28, 2023
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A Madhi, Benjamin J Cowling, et al.
Antiviral Research
|
July 31, 2012
Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro
Lisa Sandmann, Matthew Wilson, David Back, et al.
Page
of 23
Search research articles
Search
Showing results (51-60 of 223) with videos related to
Sort By:
Page
of 23
The Journal of Infectious Diseases
|
November 7, 2012
Transmission of hepatitis C virus among people who inject drugs: viral stability and association with drug preparation equipment
Juliane Doerrbecker, Patrick Behrendt, Pedro Mateu-Gelabert, et al.
The Journal of Infectious Diseases
|
May 6, 2010
How stable is the hepatitis C virus (HCV)? Environmental stability of HCV and its susceptibility to chemical biocides
Sandra Ciesek, Martina Friesland, Jörg Steinmann, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 2, 2020
Lack of antiviral activity of darunavir against SARS-CoV-2
Sandra De Meyer, Denisa Bojkova, Jindrich Cinatl, et al.
Molecular & Cellular Proteomics : MCP
|
March 31, 2023
SARS-CoV-2 Variants Show Different Host Cell Proteome Profiles With Delayed Immune Response Activation in Omicron-Infected Cells
Melinda Metzler, Rebecca George Tharyan, Kevin Klann, et al.
Stem Cell Reports
|
September 20, 2020
Human Mesenchymal Stromal Cells Are Resistant to SARS-CoV-2 Infection under Steady-State, Inflammatory Conditions and in the Presence of SARS-CoV-2-Infected Cells
Richard Schäfer, Gabriele Spohn, Marco Bechtel, et al.
Transplantation
|
March 15, 2006
Anti-HBc seroconversion after transplantation of anti-HBc positive nonliver organs to anti-HBc negative recipients
Paraskevi Fytili, Sandra Ciesek, Michael P Manns, et al.
Frontiers in Immunology
|
June 8, 2023
SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A Madhi, Benjamin J Cowling, et al.
PNAS Nexus
|
January 30, 2023
Omicron variant of SARS-CoV-2 exhibits an increased resilience to the antiviral type I interferon response
Lyudmila Shalamova, Ulrike Felgenhauer, Jochen Wilhelm, et al.
Frontiers in Immunology
|
June 28, 2023
Corrigendum: SARS-CoV-2 Omicron variants: burden of disease, impact on vaccine effectiveness and need for variant-adapted vaccines
Shanti Pather, Shabir A Madhi, Benjamin J Cowling, et al.
Antiviral Research
|
July 31, 2012
Anti-retroviral drugs do not facilitate hepatitis C virus (HCV) infection in vitro
Lisa Sandmann, Matthew Wilson, David Back, et al.
Page
of 23